High bleeding risk patients: from clinical evidence to routine practice

Sponsored by Biosensors International Group

Chairperson: C.K. Naber

Learning Objectives

  • To understand the criteria for high bleeding risk patients and to identify these patients in clinical practice
  • To discuss how the latest cutting-edge clinical evidence gives physicians the freedom to treat high bleeding risk patients
  • To understand how BA9 stents technology allows to tailor the DAPT duration to the individual patient

Presentations available when logged in:

  • Session objectives
  • LEADERS Free two years follow-up case
  • How to manage a patient at high risk of surgery
  • The emergency patient
  • Key learnings